BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4992650)

  • 1. Vaccine prophylaxis for pseudomonas infections.
    Markley K
    Ann Intern Med; 1971 Jan; 74(1):140. PubMed ID: 4992650
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
    Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E
    Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
    Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
    Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprophylaxis of Pseudomonas aeruginosa.
    Young LS; Armstrong D; Markley K
    Ann Intern Med; 1971 Jun; 74(6):1012-3. PubMed ID: 4996343
    [No Abstract]   [Full Text] [Related]  

  • 5. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
    Jones RJ; Lowbury EJ
    Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological control of pseudomonas infection in burns.
    R I Med J; 1972 Mar; 55(3):88. PubMed ID: 4622683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
    [No Abstract]   [Full Text] [Related]  

  • 9. Low mortality in burned patients in a Pseudomonas vaccine trial.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
    [No Abstract]   [Full Text] [Related]  

  • 11. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection.
    Montie TC; Drake D; Sellin H; Slater O; Edmonds S
    Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of invasive pseudomonas infection in burns with a new vaccine.
    Alexander JW; Fisher MW; MacMillan BG; Altemeier WA
    Arch Surg; 1969 Aug; 99(2):249-56. PubMed ID: 4978523
    [No Abstract]   [Full Text] [Related]  

  • 13. Protection by vaccination against Pseudomonas infection after thermal injury.
    Markley K; Smallman E
    J Bacteriol; 1968 Oct; 96(4):867-74. PubMed ID: 4971892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological control of Pseudomonas infection in burn patients: a clinical evaluation.
    Alexander JW; Fisher MW; MacMillan BG
    Arch Surg; 1971 Jan; 102(1):31-5. PubMed ID: 4992359
    [No Abstract]   [Full Text] [Related]  

  • 15. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA; Jones RJ
    Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and passive immunization with Pseudomonas aeruginosa ribosomal vaccines and antisera in the burned rat model.
    Lieberman MM; Walker HL; Ayala E; Chapa I
    J Surg Res; 1986 Feb; 40(2):138-44. PubMed ID: 3080639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1980 Dec; 2(8207):1263-5. PubMed ID: 6108445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early protection by vaccines in burns.
    Jones RJ
    Br J Exp Pathol; 1971 Feb; 52(1):100-9. PubMed ID: 4993954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problem of prevention of septic complications in burns].
    Klimenko LF; Riabaia RD
    Klin Khir (1962); 1980 Mar; (3):42-4. PubMed ID: 6768926
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients.
    Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J
    Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.